Cheaper drugs and techniques to fulfill chief executive officer perspectives - any choices?

Current Opinion in Anaesthesiology
Betty E Thomas, Thomas Ledowski

Abstract

Against the background of increasing healthcare costs and diminishing budgets, this review aims to present clinicians with ethically viable options to overcome budgetary restraints when seeking to introduce novel products. Healthcare administrators and primary healthcare providers are not unlikely to have different opinions when discussing the introduction of novel products. However, rather than taking a 'no' for an answer, doctors may be able to argue for a change - even if this may seem to come at a higher cost. The recent introduction of the reversal agent sugammadex may provide a timely example for the possibility of success 'against all financial odds'. Health professionals have the responsibility to deliver high-quality care while acknowledging the financial budget constraints. However, evidence (vs. perception) for outcome benefits of novel drugs or devices should stimulate a robust desire for their timely introduction. Demonstrating actual benefits understandable to administrators, seeking alliances with other medical specialties or patient groups, as well as negotiations with the healthcare industry may all represent viable options. Simply waiting for patents to expire should remain a measure of last resort.

References

Nov 3, 1998·Anaesthesia·W L Rowe
Dec 2, 2004·Nature Reviews. Drug Discovery·Gregory Glass
Jul 27, 2010·Journal of Health Economics·Michael R Law, Karen A Grépin
Feb 2, 2011·Annals of Internal Medicine·Douglas K OwensUNKNOWN Clinical Guidelines Committee of the American College of Physicians
Dec 14, 2011·Current Opinion in Anaesthesiology·Thomas Fuchs-BuderJan U Schreiber
Mar 16, 2012·Anaesthesia and Intensive Care·N M Gibbs, P C A Kam
Aug 16, 2015·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Janet Martin, Davy Cheng
May 12, 2016·Current Opinion in Anaesthesiology·Claude Meistelman, François Donati
Jul 16, 2016·ClinicoEconomics and Outcomes Research : CEOR·Edoardo De RobertisGiuseppe Servillo
Mar 16, 2017·Nature Reviews. Clinical Oncology·Vinay PrasadSham Mailankody
Jul 12, 2017·Anaesthesia·C R Bailey
Oct 3, 2018·Anesthesiology·Lee A Fleisher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Sharon Brownie
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Andrew Peters
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Andrew Peters
© 2022 Meta ULC. All rights reserved